◆ Clinical parkinsonism & related disorders2026-01-01
Continuous subcutaneous foscarbidopa/foslevodopa infusion as a therapeutic option in spinocerebellar ataxia type 8 presenting with early-onset parkinsonism.
Francesco Onorati, Lorenzo Malfer, Lauren M Jackson, Zhiyv Niu, Owen A Ross, Rodolfo Savica
原始摘要（英文原文）· Original abstract
In response to a case report on a patient with spinocerebellar ataxia type 8, presenting with early-onset parkinsonism and treated with deep brain stimulation, we report an analogous case, who responded optimally to continuous subcutaneous foscarbidopa/foslevodopa infusion.
Continuous subcutaneous foscarbidopa/foslevodopa infusion as a therapeutic option in spinocerebellar ataxia type 8 presenting with early-onset parkinsonism. — 科研速览 Science Skim